Advertisement

Pneumococcal Vaccination Among Adults With Work-related Asthma

  • Katelynn E. Dodd
    Correspondence
    Address correspondence to: Katelynn E. Dodd, MPH, Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, 1095 Willowdale Road, MS HG900, Morgantown WV 26505
    Affiliations
    Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia
    Search for articles by this author
  • Jacek M. Mazurek
    Affiliations
    Respiratory Health Division, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention, Morgantown, West Virginia
    Search for articles by this author
Published:September 27, 2017DOI:https://doi.org/10.1016/j.amepre.2017.07.022

      Introduction

      Pneumococcal vaccination is recommended for all adults with asthma and a Healthy People 2020 goal aims to achieve 60% coverage among high-risk adults, including those with asthma. Adults with work-related asthma have more severe asthma symptoms than those with non−work-related asthma and are particularly vulnerable to pneumococcal pneumonia.

      Methods

      To assess pneumococcal vaccination coverage by work-related asthma status among ever-employed adults aged 18–64 years with current asthma, data from the 2012–2013 Behavioral Risk Factor Surveillance System Asthma Call-back Survey for ever-employed adults (18–64 years) with current asthma from 29 states were examined in 2016. Adults with work-related asthma had ever been told by a physician their asthma was work-related. Pneumococcal vaccine recipients self-reported having ever received a pneumococcal vaccine. Multivariate logistic regression was used to calculate adjusted prevalence ratios and associated 95% CIs.

      Results

      Among an estimated 12 million ever-employed adults with current asthma in 29 states, 42.0% received a pneumococcal vaccine. Adults with work-related asthma were more likely to have received a pneumococcal vaccine than adults with non−work-related asthma (53.7% versus 35.0%, respectively, prevalence ratio=1.24, 95% CI=1.06, 1.45). Among adults with work-related asthma, pneumococcal vaccine coverage was lowest among Hispanics (36.2%) and those without health insurance (38.5%).

      Conclusions

      Pneumococcal vaccination coverage among adults with work-related asthma and non−work-related asthma is below the Healthy People 2020 target level. Healthcare providers should verify pneumococcal vaccination status in their patients with asthma and offer the vaccine to those not vaccinated.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • CDC
        Summary Health Statistics: National Health Interview Survey. 2015; (Published 2016. Accessed May 18, 2017)
        • Talbot T.R.
        • Hartert T.V.
        • Mitchel E.
        • et al.
        Asthma as a risk factor for invasive pneumococcal disease.
        N Engl J Med. 2005; 352: 2082-2090https://doi.org/10.1056/NEJMoa044113
        • Juhn Y.J.
        • Kita H.
        • Yawn B.P.
        • et al.
        Increased risk of serious pneumococcal disease in patients with asthma.
        J Allergy Clin Immunol. 2008; 122: 719-723https://doi.org/10.1016/j.jaci.2008.07.029
        • Flory J.H.
        • Joffe M.
        • Fishman N.O.
        • Edelstein P.H.
        • Metlay J.P.
        Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults.
        Epidemiol Infect. 2009; 137: 717-726https://doi.org/10.1017/S0950268808001489
        • Inghammar M.
        • Engstrom G.
        • Kahlmeter G.
        • Ljungberg B.
        • Lofdahl C.G.
        • Egesten A.
        Invasive pneumococcal disease in patients with an underlying pulmonary disorder.
        Clin Microbiol Infect. 2013; 19: 1148-1154https://doi.org/10.1111/1469-0691.12182
        • Torres A.
        • Menendez R.
        • Wunderink R.
        Bacterial pneumonia and lung abscess.
        in: Broaddus V. Mason R. Ernst J. Murray & Nadel's Textbook of Respiratory Medicine. 6 ed. Elsevier Saunders, Philadelphia, PA2016: 557-582
        • Pesek R.
        • Lockey R.
        Vaccination of adults with asthma and COPD.
        Allergy. 2011; 66: 25-31https://doi.org/10.1111/j.1398-9995.2010.02462.x
        • CDC
        Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
        MMWR Morb Mortal Wkly Rep. 2010; 59: 1102-1106
        • Tarlo S.M.
        • Balmes J.
        • Balkissoon R.
        • et al.
        Diagnosis and management of work-related asthma: American College Of Chest Physicians Consensus Statement.
        Chest. 2008; 134: 1S-41Shttps://doi.org/10.1378/chest.08-0201
        • Knoeller G.E.
        • Mazurek J.M.
        • Moorman J.E.
        Characteristics associated with health care professional diagnosis of work-related asthma among individuals who describe their asthma as being caused or made worse by workplace exposures.
        J Occup Environ Med. 2012; 54: 485-490https://doi.org/10.1097/JOM.0b013e3182479f93
        • O’Byrne P.M.
        • Pedersen S.
        • Schatz M.
        • et al.
        The poorly explored impact of uncontrolled asthma.
        Chest. 2013; 143 (523): 511https://doi.org/10.1378/chest.12-0412
        • Weycker D.
        • Farkouh R.A.
        • Strutton D.R.
        • Edelsberg J.
        • Shea K.M.
        • Pelton S.I.
        Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions.
        BMC Health Serv Res. 2016; 16: 182https://doi.org/10.1186/s12913-016-1432-4
      1. U.S. DHHS. 2020 Topics & Objectives. Immunization and Infectious Diseases. www.healthypeople.gov/2020/topics-objectives/topic/immunization-and-infectious-diseases/objectives. Published September 22, 2016. Accessed September 23, 2016.

      2. CDC. Behavioral Risk Factor Surveillance System. www.cdc.gov/brfss/about/index.htm. Published May 16, 2014. Accessed April 27, 2015.

      3. CDC. BRFSS Asthma Call-back Survey. www.cdc.gov/brfss/acbs/index.htm. Published July 2, 2015. Accessed April 27, 2015.

        • Knoeller G.E.
        • Mazurek J.M.
        • Moorman J.E.
        Asthma symptoms among adults with work-related asthma.
        J Asthma. 2013; 50: 166-173https://doi.org/10.3109/02770903.2012.754029
        • Knoeller G.E.
        • Mazurek J.M.
        • Moorman J.E.
        Work-related asthma, financial barriers to asthma care, and adverse asthma outcomes: Asthma Call-back Survey, 37 states and District of Columbia, 2006 to 2008.
        Med Care. 2011; 49: 1097-1104https://doi.org/10.1097/MLR.0b013e31823639b9
      4. Expert Panel Report 3 (EPR-3): Guidelines for the Diagnosis and Management of Asthma-Summary Report 2007.
        J Allergy Clin Immunol. 2007; 120: S94-S138https://doi.org/10.1016/j.jaci.2007.09.029
        • Mirsaeidi M.
        • Ebrahimi G.
        • Allen M.B.
        • Aliberti S.
        Pneumococcal vaccine and patients with pulmonary diseases.
        Am J Med. 2014; 127: 886https://doi.org/10.1016/j.amjmed.2014.05.010
      5. CDC. PCV13 (pneumococcal conjugate) vaccine. www.cdc.gov/vaccines/vpd-vac/pneumo/vac-pcv13-adults.htm. Published September 3, 2015. Accessed October 6, 2016.

        • CDC
        Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Morb Mortal Wkly Rep. 2012; 61: 816-819
      6. CDC. Vaccine contraindications and precautions for adults only. www.cdc.gov/vaccines/hcp/admin/contraindications-adults.html. Published March 6, 2014. Accessed September 21, 2016.

        • Rehm S.J.
        • File T.M.
        • Metersky M.
        • Nichol K.L.
        • Schaffner W.
        Identifying barriers to adult pneumococcal vaccination: an NFID task force meeting.
        Postgrad Med. 2012; 124: 71-79https://doi.org/10.3810/pgm.2012.05.2550
        • Lu P.J.
        • O’Halloran A.
        • Williams W.W.
        Impact of health insurance status on vaccination coverage among adult populations.
        Am J Prev Med. 2015; 48: 647-661https://doi.org/10.1016/j.amepre.2014.12.008
        • White G.E.
        • Mazurek J.M.
        • Moorman J.E.
        Work-related asthma and employment status—38 states and District of Columbia, 2006–2009.
        J Asthma. 2013; 50: 954-959https://doi.org/10.3109/02770903.2013.829491
        • Le Moual N.
        • Kauffmann F.
        • Eisen E.A.
        • Kennedy S.M.
        The healthy worker effect in asthma: work may cause asthma, but asthma may also influence work.
        Am J Respir Crit Care Med. 2008; 177: 4-10https://doi.org/10.1164/rccm.200703-415PP
        • Torres A.
        • Blasi F.
        • Dartois N.
        • Akova M.
        Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease.
        Thorax. 2015; 70: 984-989https://doi.org/10.1136/thoraxjnl-2015-206780
        • Kleinman N.L.
        • Yu H.
        • Beren I.A.
        • Sato R.
        Work-related and health care cost burden of community-acquired pneumonia in an employed population.
        J Occup Environ Med. 2013; 55: 1149-1156https://doi.org/10.1097/JOM.0b013e3182a7e6af
        • Mazurek J.M.
        • White G.E.
        • Moorman J.E.
        • Storey E.
        Influenza vaccination among persons with work-related asthma.
        Am J Prev Med. 2014; 47: 203-211https://doi.org/10.1016/j.amepre.2014.04.007
        • Postema A.S.
        • Breiman R.F.
        Adult immunization programs in nontraditional settings: quality standards and guidance for program evaluation.
        MMWR Recomm Rep. 2000; 49: 1-13
        • McKeever T.
        • Harrison T.W.
        • Hubbard R.
        • Shaw D.
        Inhaled corticosteroids and the risk of pneumonia in people with asthma: a case-control study.
        Chest. 2013; 144: 1788-1794https://doi.org/10.1378/chest.13-0871
        • Okoro C.A.
        • Zhao G.
        • Fox J.B.
        • Eke P.I.
        • Greenlund K.J.
        • Town M.
        Surveillance for Health Care Access and Health Services Use, Adults Aged 18–64 Years—Behavioral Risk Factor Surveillance System, United States, 2014.
        MMWR Surveill Summ. 2017; 66: 1-42https://doi.org/10.15585/mmwr.ss6607a1
        • Stewart A.M.
        • Lindley M.C.
        • Cox M.A.
        State law and standing orders for immunization services.
        Am J Prev Med. 2016; 50: e133-e142https://doi.org/10.1016/j.amepre.2015.10.003
      7. Ohio Revised Code. In: § 3727.19 (C); 2006.

        • Smith J.G.
        • Metzger N.L.
        Evaluation of pneumococcal vaccination rates after vaccine protocol changes and nurse education in a tertiary care teaching hospital.
        J Manag Care Pharm. 2011; 17: 701-708https://doi.org/10.18553/jmcp.2011.17.9.701
        • Albert S.M.
        • Nowalk M.P.
        • Yonas M.A.
        • Zimmerman R.K.
        • Ahmed F.
        Standing orders for influenza and pneumococcal polysaccharide vaccination: correlates identified in a national survey of U.S. primary care physicians.
        BMC Fam Pract. 2012; 13: 22https://doi.org/10.1186/1471-2296-13-22
        • Wyrwich K.W.
        • Yu H.
        • Sato R.
        • Strutton D.
        • Powers J.H.
        Community-acquired pneumonia: symptoms and burden of illness at diagnosis among U.S. adults aged 50 years and older.
        Patient. 2013; 6: 125-134https://doi.org/10.1007/s40271-013-0013-4
        • Legiest B.
        • Nemery B.
        Management of work-related asthma: guidelines and challenges.
        Eur Respir Rev. 2012; 21: 79-81https://doi.org/10.1183/09059180.00002912